Peter Vranes is a Co-founder of Nutromics, an Australian med-tech company providing continuous, real-time molecular monitoring using a smart patch biosensor platform. In this episode, Peter shares his story from having already built and exited a successful cosmeceutical brand and how that led to meeting his co-founder to build Nutromics. He also talks about how that experience led to them participating in a med-tech accelerator, and their journey through capital raising and biosensor supported proof of concepts.

 

Key takeaways:

1. Conventional molecular tests and monitoring leaves big gaps in terms of the information needed to support decision making (especially where monitoring of fast-moving molecular targets is needed), biosensors are set to revolutionize healthcare.
2. Nutromics has developed a one patch platform that can be adapted to many applications and can ensure, continuously and in real-time, that a patient is receiving a dose at the right time and level to stay within the therapeutic range.
3. The molecular biosensing technology has a microneedle array platform and an aptamer sensor platform that promises flexibility for this Smart Patch to be used in many different therapeutic contexts.

 

Resources and links:

• https://www.linkedin.com/in/peter-vranes-085bb810/
• https://www.nutromics.com.au/

 

Connect:

• Listen to other episodes of Reimagining Healthcare
• Connect with Yianni Serpanos on LinkedIn
• Follow HealthTechX on LinkedIn
• Follow HealthTechX on Instagram
• Follow HealthTechX on Meetup

LinkedIn Company Page: https://www.linkedin.com/company/healthtechx/

See omnystudio.com/listener for privacy information.